A patient with systemic lupus erythematosus (SLE) presents with mild anemia, leukopenia, thrombocytopenia, elevated ESR, and proteinuria. Considering these findings, which nursing intervention is the priority to address the patient's condition?

A) Monitor vital signs and assess for signs of infection.

B) Educate the patient on the importance of a high-protein diet.

C) Encourage increased fluid intake to promote renal function.

D) Initiate contact precautions to prevent the spread of infection.

A patient with systemic lupus erythematosus (SLE) presents with mild anemia, leukopenia, thrombocytopenia, elevated ESR, and proteinuria. Given these findings, what is the most appropriate nursing intervention to prioritize in the management of this patient?

C) Monitor for signs of infection due to leukopenia.

A) Encourage increased fluid intake to improve renal function.

B) Administer prescribed corticosteroids to reduce inflammation.

C) Monitor for signs of infection due to leukopenia.

D) Recommend a high-protein diet to address proteinuria.

A patient with systemic lupus erythematosus presents with fatigue, dyspnea, hypotension, and peripheral edema. The nursing team is preparing to initiate intravenous corticosteroids. What is the nurse's priority action before starting this treatment?

A) Obtain a baseline blood glucose level.

B) Ensure the patient is on a low-sodium diet.

C) Administer supplemental oxygen.

D) Position the patient in a supine position.

A 28-year-old female patient with systemic lupus erythematosus is experiencing a deterioration in clinical status characterized by tachycardia, hypotension, and dyspnea at rest, along with laboratory indicators of anemia and renal impairment. Which nursing intervention is the most appropriate to prioritize at this time?

C) Administer intravenous corticosteroids as prescribed.

A) Administer intravenous fluids to address hypotension.

B) Prepare the patient for immediate dialysis.

C) Administer intravenous corticosteroids as prescribed.

D) Educate the patient about dietary modifications to reduce proteinuria.

A patient with lupus is experiencing mixed responses to treatment, including improved respiratory function but persistent cardiovascular issues. Which nursing intervention is the priority to address the patient's low blood pressure and increased heart rate?

B) Administer prescribed low-dose diuretic to manage fluid overload and monitor blood pressure closely.

A) Increase the rate of IV fluid administration to quickly raise blood pressure.

B) Administer prescribed low-dose diuretic to manage fluid overload and monitor blood pressure closely.

C) Encourage the patient to ambulate frequently to improve circulation and cardiac output.

D) Hold all medications until the cardiologist can reassess the patient's cardiovascular status.

A patient with lupus is experiencing mixed responses to a treatment plan adjustment. With her current condition showing improved dyspnea and stable oxygen saturation but persistent low blood pressure and increased heart rate, which nursing intervention should be prioritized to address her cardiovascular status?

B) Administer a low-dose diuretic as prescribed to manage fluid overload.

A) Increase the patient's fluid intake to elevate blood pressure.

B) Administer a low-dose diuretic as prescribed to manage fluid overload.

C) Withhold antihypertensive medications to prevent further blood pressure drop.

D) Encourage ambulation to improve peripheral circulation.

A patient with systemic lupus erythematosus is receiving a low-dose diuretic and presents with increased fatigue, a throbbing headache, a slightly elevated blood pressure, tachycardia, and worsening renal function. Which nursing action is the priority to address the patient's current symptoms and laboratory findings?

D) Hold the next dose of diuretic and assess for signs of fluid overload.

A) Increase fluid intake to counteract the effects of the diuretic.

B) Notify the healthcare provider about the potential neuropsychiatric symptoms and request an MRI.

C) Monitor the patient's neurological status closely for signs of neuropsychiatric lupus.

D) Hold the next dose of diuretic and assess for signs of fluid overload.

A patient with systemic lupus erythematosus (SLE) is being treated with a low-dose diuretic for fluid management. She presents with increased fatigue, a throbbing headache, and laboratory findings indicate thrombocytopenia and worsened renal function. What is the most appropriate nursing intervention to prioritize at this time?

B) Monitor the patient for signs of bleeding and notify the healthcare provider of the platelet count.

A) Administer acetaminophen for the headache as prescribed and recheck vital signs in 2 hours.

B) Monitor the patient for signs of bleeding and notify the healthcare provider of the platelet count.

C) Increase the frequency of blood pressure monitoring and prepare to administer antihypertensive medication.

D) Educate the patient about maintaining a low-sodium diet to manage fluid retention.

A patient with systemic lupus erythematosus (SLE) is experiencing a flare, as indicated by elevated anti-dsDNA antibodies and decreased complement levels. The healthcare team has decided to taper off a diuretic due to worsening renal function and initiate a low-dose corticosteroid. Which nursing intervention is most appropriate to prioritize in this situation?

C) Assess the patient's blood pressure and adjust antihypertensive medication as needed.

A) Educate the patient on potential side effects of corticosteroids, including weight gain and mood changes.

B) Monitor the patient's blood glucose levels regularly to detect corticosteroid-induced hyperglycemia.

C) Assess the patient's blood pressure and adjust antihypertensive medication as needed.

D) Perform frequent neurological assessments to detect any signs of neuropsychiatric involvement.

A patient with systemic lupus erythematosus (SLE) is experiencing a lupus flare characterized by fatigue, headache, worsening renal function, and thrombocytopenia. The healthcare team initiates a low-dose corticosteroid and adjusts antihypertensive therapy. Which nursing intervention is most important to prioritize in the care of this patient?

C) Assess for signs of neuropsychiatric involvement, such as changes in cognition or mood.

A) Monitor daily weights and intake/output to prevent fluid overload.

B) Educate the patient on recognizing signs of infection due to immunosuppressive therapy.

C) Assess for signs of neuropsychiatric involvement, such as changes in cognition or mood.

D) Encourage the patient to engage in regular physical activity to combat fatigue.

systemic Lupus erythematosis - Nursing Case Study

Pathophysiology

• Primary mechanism: Systemic Lupus Erythematosus (SLE) involves the production of autoantibodies against nuclear antigens, leading to the formation of immune complexes. These complexes deposit in tissues, triggering inflammation and tissue damage across multiple organ systems.

• Secondary mechanism: The complement system is often activated due to these immune complexes, contributing to further inflammation and damage. Additionally, impaired clearance of apoptotic cells exacerbates the autoimmune response, perpetuating the cycle of tissue injury.

• Key complication: Immune complex deposition and complement activation can lead to glomerulonephritis, causing kidney damage. This is a major complication in SLE, highlighting the importance of monitoring renal function in affected patients.

Patient Profile

Demographics:

29-year-old female, elementary school teacher

History:

• Key past medical history: Diagnosed with systemic lupus erythematosus (SLE) 3 years ago, mild renal involvement, history of photosensitivity

• Current medications: Hydroxychloroquine 200 mg daily, Prednisone 10 mg daily, Methotrexate 15 mg weekly, supplements including vitamin D and calcium

• Allergies: Penicillin (rash)

Current Presentation:

• Chief complaint: Increasing fatigue and joint pain

• Key symptoms: Symmetrical joint swelling, oral ulcers, mild hair loss, intermittent low-grade fever, and a recent increase in facial rash

• Vital signs: Blood pressure 145/90 mmHg, heart rate 92 bpm, respiratory rate 20 breaths per minute, temperature 100.2°F

Section 1

New Diagnostic Results:

As the healthcare team continues to assess the patient's condition, several diagnostic tests are ordered to better understand the progression of her systemic lupus erythematosus (SLE) and the underlying cause of her increasing symptoms. A complete blood count (CBC) reveals a mild anemia with a hemoglobin level of 10.5 g/dL, leukopenia with a white blood cell count of 3,500 /μL, and thrombocytopenia with a platelet count of 130,000 /μL. These findings suggest hematological involvement, which is not uncommon in SLE patients due to autoantibody-mediated destruction of blood cells. Additionally, her erythrocyte sedimentation rate (ESR) is elevated at 65 mm/hr, indicating active inflammation, and her C-reactive protein (CRP) level is moderately increased.

Further lab tests focus on her renal function, given her history of mild renal involvement. Serum creatinine is slightly elevated at 1.4 mg/dL, and a urinalysis reveals proteinuria with 1.5 grams of protein per day, indicative of worsening renal function and potential progression to lupus nephritis. Complement levels, specifically C3 and C4, are decreased, consistent with active lupus flares as the complement system is consumed in combating immune complex deposition. These results underscore the need for a reassessment of her current treatment regimen to prevent further organ damage and manage her symptoms more effectively.

These diagnostic findings highlight the complexity of managing SLE and the necessity for ongoing monitoring and timely intervention. The evidence of renal involvement and hematological abnormalities necessitates a multidisciplinary approach, potentially involving nephrology and hematology specialists, to adjust her treatment plan. This may include increasing her immunosuppressive therapy or considering alternative medications to mitigate the autoimmune response and manage her symptoms. The healthcare team must weigh the benefits of intensifying treatment against potential side effects, particularly given her current medication regimen, to optimize patient outcomes.

Section 2

Change in Patient Status:

The patient's clinical status has deteriorated over the past 48 hours, prompting an urgent reassessment by the healthcare team. She presents with increased fatigue, generalized malaise, and new-onset dyspnea at rest. Upon examination, her vital signs reveal tachycardia with a heart rate of 110 beats per minute, hypotension with a blood pressure of 88/56 mmHg, and tachypnea with a respiratory rate of 24 breaths per minute. Additionally, she exhibits peripheral edema and mild jugular venous distention, raising concerns for fluid overload potentially related to worsening renal function or cardiac involvement.

Further laboratory analysis indicates a significant drop in her hemoglobin to 9.0 g/dL, suggesting worsening anemia, and her platelet count has decreased further to 115,000 /μL. Her serum creatinine has risen to 1.8 mg/dL, and her proteinuria has increased to 2.3 grams per day, confirming the progression of her renal impairment. An echocardiogram is ordered and reveals a mild pericardial effusion, consistent with lupus-related pericarditis, which may be contributing to her hemodynamic instability.

These findings necessitate immediate intervention, including adjustments to her immunosuppressive therapy to address the lupus flare and consultation with nephrology and cardiology to manage her renal and cardiac complications. The team considers initiating intravenous corticosteroids to rapidly control inflammation and revises her fluid management plan to address her renal status and avoid exacerbating the pericardial effusion. Close monitoring of her cardiovascular and renal function is essential as they work to stabilize her condition and prevent further complications.

Section 3

Two days following the adjustments to her treatment plan, the patient's condition shows mixed responses to the interventions. Her dyspnea has slightly improved with a respiratory rate now reduced to 20 breaths per minute, and her oxygen saturation is stable at 95% on room air. However, her blood pressure remains low at 90/58 mmHg despite cautious fluid management, and her heart rate has increased to 115 beats per minute, suggesting ongoing cardiovascular stress. Her peripheral edema persists, and she continues to exhibit mild jugular venous distention.

Laboratory results reveal a slight improvement in her hemoglobin, now at 9.5 g/dL, indicating a positive response to the treatment for anemia. However, her platelet count has further declined to 105,000 /μL, raising concerns about potential hematological complications related to lupus. Her serum creatinine remains elevated at 1.9 mg/dL, indicating persistent renal impairment. The proteinuria has decreased marginally to 2.1 grams per day, suggesting some stabilization of renal function.

The healthcare team is now faced with the challenge of balancing immunosuppressive therapy to control the lupus flare while addressing her cardiovascular status. Nephrology and cardiology consultations emphasize the need for cautious titration of medications to manage the pericardial effusion without compromising renal function. The decision is made to initiate a low-dose diuretic to improve fluid management, alongside continued monitoring of her renal parameters and hemodynamic status. The team remains vigilant for signs of further complications, such as infection or thromboembolic events, as they work to stabilize the patient and prevent additional deterioration.

Section 4

Three days after the initiation of a low-dose diuretic, the patient presents with a mixed clinical picture. Her peripheral edema has notably decreased, and the jugular venous distention is less pronounced, indicating some improvement in fluid management. However, during the morning assessment, she reports increased fatigue and a throbbing headache. Vital signs show a slightly elevated blood pressure at 94/60 mmHg, and her heart rate remains tachycardic at 110 beats per minute.

New laboratory results reveal a further drop in her platelet count to 95,000 /μL, heightening the concern for lupus-associated thrombocytopenia. Her serum creatinine has slightly worsened, now at 2.1 mg/dL, suggesting a potential adverse effect of the diuretic on renal function. Additionally, a repeat urinalysis shows persistent proteinuria at 2.0 grams per day. These findings prompt the healthcare team to weigh the risks of continuing the diuretic against the potential for exacerbating renal impairment.

Given the patient's headache and fatigue, the team investigates for possible central nervous system involvement, a known complication of systemic lupus erythematosus. She undergoes a neurological examination, which is unremarkable, yet the team remains vigilant for subtle signs of neuropsychiatric lupus. An MRI is ordered to rule out cerebral vasculitis or microinfarcts, and a thorough review of her current medication regimen is conducted to identify any potential contributors to her altered symptoms. The team continues to balance her treatment for lupus flare with the management of her cardiovascular and renal status, prioritizing vigilant monitoring and timely adjustments to her therapeutic plan.

Section 5

As the healthcare team continues to manage the patient's complex condition, new diagnostic results offer further insights that guide their clinical reasoning. The MRI reveals no overt signs of cerebral vasculitis or microinfarcts, providing some reassurance against immediate central nervous system complications. However, the persistence of the patient's fatigue and headache prompts a closer examination of her inflammatory markers. Laboratory tests indicate elevated levels of anti-dsDNA antibodies and decreased complement levels (C3 and C4), suggesting active disease. These findings reinforce the suspicion of a lupus flare, likely exacerbated by the recent changes in her medication regimen.

In light of the worsening renal function and thrombocytopenia, the healthcare team decides to cautiously taper off the diuretic, considering its potential contribution to the patient's declining renal function. Instead, they initiate a low-dose corticosteroid to address the lupus flare and its systemic effects, including the persistent proteinuria. Additional supportive measures include optimizing her fluid balance without overloading her kidneys, and adjusting antihypertensive therapy to stabilize her blood pressure without causing hypotension.

Throughout this period, the team remains vigilant for new complications, particularly signs of neuropsychiatric involvement or further hematological changes. Regular monitoring of her platelet count and renal function is prioritized, as is ongoing assessment of her neurological status. The patient is educated about the importance of reporting any new or worsening symptoms, including changes in cognition or mood, as the team seeks to refine her treatment plan while minimizing adverse effects. This approach underscores the complexity of managing systemic lupus erythematosus, where clinical reasoning must continuously adapt to the dynamic interplay of symptoms and treatment responses.